Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and…
15 analysts rate NVST Buy on consensus.
Consensus price target: $28.69 (+20.72% upside from $23.77)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Reis Mischa SVP, Strategy & Bus. Dev. | Feb 10, 2026 | Sale | 5,634 | $169.02K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $2.72B | +8.32% | $47M |
| 2024 | $2.51B | -2.18% | $-1.12B |
| 2023 | $2.57B | -0.1% | $-100.2M |
Stock data for NVST: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics